Im Oktober 2005 erschien der Arzneiverordnungs-Report 2005 (1). Er beschreibt wie allj\u00e4hrlich die Verordnungspraxis im Bereich der gesetzlichen Krankenversicherung (GKV) nach Analyse der 400 Millionen ausgestellten Rezepte. Durch das GKV-Modernisierungsgesetz haben sich bekannterma\u00dfen ganz erhebliche \u00c4nderungen ergeben, die die Kosten in diesem Bereich um 2,5 Milliarden EUR auf 21,7 Milliarden EUR gesenkt haben. Auf die […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Im Oktober 2005 erschien der Arzneiverordnungs-Report 2005 (1). Er beschreibt wie allj\u00e4hrlich die Verordnungspraxis im Bereich der gesetzlichen Krankenversicherung (GKV) nach Analyse der 400 Millionen ausgestellten Rezepte. Durch das GKV-Modernisierungsgesetz haben sich bekannterma\u00dfen ganz erhebliche \u00c4nderungen ergeben, die die Kosten in diesem Bereich um 2,5 Milliarden EUR auf 21,7 Milliarden EUR gesenkt haben. Auf die […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1361,122,1371,776,137,123,909,255,523,524,1376,1023,1358,1378,61,1354,1379,1377,1353,324,1365,711,146,526,1372,1359,1367,1366,1355,1360,48,1326,1374,1370,1375,822,1373,1356,1362,1368,1369,1363,1364,1357,1391,180,1392,125,1380,325,1395,1388,1396,430,1385,1390,1389,69,149,1381,257,1397,1393,1383,1136,1382,1398,1394,1386,70,1137,1387,1384,340,1349,1067,1345,754,338,1351,1346,54,51,1348,1352,1347,55,520,521,1344,1350],"class_list":["post-602","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-acne-vulgaris","tag-aids","tag-akne","tag-anticholinergika","tag-antikoagulanzien","tag-antiretrovirale-therapie","tag-aripiprazol","tag-arzneimittel","tag-arzneimittelverordnungen","tag-arzneiverordnungen","tag-arzneiverordnungs-report-2005","tag-atazanavir","tag-b-zell-lymphom","tag-b-zell-non-hodgkin-lymphom","tag-beinvenenthrombose","tag-belastungsinkontinenz","tag-bivalirudin","tag-blasenschwaeche","tag-blasenueberaktivitaet","tag-blutdruck","tag-bortezomib","tag-bronchialkarzinom","tag-brustkrebs","tag-buchbesprechung","tag-carglumsaeure","tag-cetuximab","tag-cholera-schluck-impfstoff","tag-cinacalcet","tag-cox-2-hemmer","tag-coxibe","tag-diabetes-mellitus","tag-diarrhoe","tag-dranginkontinenz","tag-duloxetin","tag-efalizumab","tag-eflornithin","tag-epilepsie","tag-epinastin","tag-eplerenon","tag-etoricoxib","tag-everolimus","tag-fosamprenavir","tag-fulvestrant","tag-gadotersaeure","tag-harnblase","tag-herzinsuffizienz","tag-hirsutismus","tag-hiv-infektion","tag-hyperparathyreoidismus","tag-hypertonie","tag-ibritumonab-tiuxetan","tag-insulin-detemir","tag-insulin-glusilin","tag-kolonkarzinom","tag-konjunktivitis","tag-levobupivacain","tag-lokalanaesthesie","tag-lungenembolie","tag-mammakarzinom","tag-manidipin","tag-medikamente","tag-melagatran","tag-mitotan","tag-mrt-kontrastmittel","tag-multiples-myelom","tag-nadifloxacin","tag-nebennierenkarzinom","tag-non-hodgkin-lymphom","tag-olapatadin","tag-osteoporose","tag-plasmozytom","tag-pleuramesotheliom","tag-pregabalin","tag-psoriasis","tag-racecadotril","tag-rheumatoide-arthritis","tag-schizophrenie","tag-schmerzen","tag-schuppenflechte","tag-solifenacin","tag-strontiumranelat","tag-thromboembolie","tag-thrombose","tag-transplantatabstossung","tag-ueberaktive-blase","tag-urininkontinenz","tag-venenthrombose","tag-verordnungsverhalten","tag-verschreibungsverhalten","tag-ximelagatran","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=602"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/602\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}